Towards Healthcare
Anti-Snoring Devices Market
Updated Date : 23 December 2025   |   Report Code : 6539

Anti-Snoring Devices Market Trends Supporting Future Sleep Health

The anti-snoring devices market was valued at USD 1.92 billion in 2025 and is expected to reach USD 2.06 billion in 2026, further expanding to USD 3.89 billion by 2035, growing at a CAGR of 7.34% from 2026 to 2035. This report provides detailed coverage of market size, growth dynamics, device type, gender, age group, distribution channel, and end-user segmentation, along with regional analysis across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Last Updated : 23 December 2025 Category: Medical Devices Insight Code: 6539 Format: PDF / PPT / Excel
Revenue, 2025
USD 1.92 Billion
Forecast, 2035
USD 3.89 Billion
CAGR, 2026-2035
7.34%
Report Coverage
Global

Anti-Snoring Devices Market Size, Dynamics with Key Players and Growth

The global anti-snoring devices market size was estimated at USD 1.92 billion in 2025 and is predicted to increase from USD 2.06 billion in 2026 to approximately USD 3.89 billion by 2035, expanding at a CAGR of 7.34% from 2026 to 2035.

Anti-Snoring Devices Market Trends and Growth (2026)

The anti-snoring devices market is driven by rising awareness of sleep disorders, growing adoption of homecare solutions, and increasing preference for non-invasive treatments. Technological advancements, including smart wearables and AI-enabled monitoring, are enhancing product effectiveness and user comfort. North America dominated the market due to high diagnosis rates, strong healthcare infrastructure, and widespread consumer acceptance of advanced sleep-care devices.

Key Takeaways

  • Anti-snoring devices market to crossed USD 2.06 billion by 2026.
  • Market projected at USD 3.89 billion by 2035.
  • CAGR of 7.34% expected in between 2026 to 2035.
  • North America held a major revenue share of the anti-snoring devices market in 2025.
  • Asia-Pacific is expected to witness the fastest growth during the predicted timeframe.
  • By device type, the oral appliances segment registered its dominance over the global market in 2025.
  • By device type, the EPAP therapy devices segment is expected to grow with the highest CAGR in the market during the studied years.
  • By gender, the male patients segment held the largest revenue share in the market in 2025.
  • By gender, the female patients segment is expected to show the fastest growth over the forecast period.
  • By age group, the above 60 years segment held a dominant presence in the U.S. digital mental health market in 2025.
  • By age group, the between 40-60 years segment is expected to witness the fastest growth in the market over the forecast period.
  • By distribution channel, the hospital pharmacies segment contributed the biggest revenue share in the anti-snoring devices market in 2025.
  • By distribution channel, the online pharmacies segment is expected to grow at the fastest CAGR in the market during the forecast period.
  • By end user, the home care settings segment registered its dominance over the global market in 2025.
  • By end user, the hospitals & clinics segment is expected to grow with the highest CAGR in the market during the studied years.

Executive Summary Table

Key Elements Scope
Market Size in 2026 USD 2.06 Billion
Projected Market Size in 2035 USD 3.89 Billion
CAGR (2026 - 2035) 7.34%
Leading Region North America
Market Segmentation By Device Type, By Gender, By Age Group, By Distribution Channel, By End User, By Region
Top Key Players ResMed, Philips Respironics (Royal Philips), SomnoMed, ProSomnus Sleep Technologies, Fisher & Paykel Healthcare, ZQuiet (Sleeping Well LLC), Smart Nora 

Market Overview: Innovations Shaping the Future of Anti-Snoring Devices

Anti-snoring devices are tools designed to reduce or prevent snoring by improving airflow during sleep. These devices include nasal dilators, mouthpieces, chin straps, and smart positional aids. The anti-snoring devices market is driven by rising awareness of sleep-related issues, increasing preference for non-invasive solutions, and growing demand for home-based sleep care. Additionally, technological advancements, such as sensor-based devices and app-enabled monitoring, are improving treatment effectiveness and user comfort. Expanding diagnosis of sleep apnea, higher stress levels, and lifestyle-related sleep disturbances are further supporting market adoption.

How AI is Revolutionizing the Anti-Snoring Devices Market?

AI integration can significantly enhance anti-snoring devices by enabling real-time detection, analysis, and response to snoring patterns. Using sensors and machine-learning algorithms, AI can identify sleep positions, breathing irregularities, and vibration levels, allowing devices to automatically adjust their functioning for better airflow. AI-powered systems can also personalize treatment by learning user habits over time and providing tailored recommendations through mobile apps. This improves accuracy, comfort, and long-term effectiveness. Additionally, AI-enabled data tracking helps users and healthcare professionals gain deeper insights into sleep quality, making anti-snoring therapy more proactive and user-centric.

  • Smart and Connected Devices – Anti-snoring devices are increasingly integrating sensors and mobile app connectivity to monitor sleep patterns and provide real-time feedback for improved comfort and usability.
  • Home-Based and Wearable Solutions – There is growing demand for convenient, non-invasive devices such as oral appliances, positional trainers, and wearable aids, driven by rising consumer focus on sleep health.
  • Customizable and 3D-Printed Devices – Advances in 3D printing allow oral appliances to be tailored to individual users, enhancing comfort and effectiveness.
  • Expansion in Clinical and Wellness Settings – Anti-snoring devices are being adopted in hospitals, sleep clinics, and wellness programs, highlighting the importance of sleep health in overall well-being.
  • Comfort and Portability Enhancements – New designs emphasize lightweight, compact, and easy-to-use devices, making them more user-friendly for daily home use and travel.

Prevalence of Snoring Disorder

Major Investment / Government Initiatives

  • In November 2025, the Centers for Medicare & Medicaid Services (CMS) expanded coverage criteria for oral appliance therapy for sleep apnea, improving reimbursement and access to anti-snoring devices.
  • In August 2025, the National Heart, Lung, and Blood Institute (NHLBI) Sleep Health Initiative in the U.S. allocated US$3.6 million for sleep disorder research and awareness programs, boosting focus on diagnosis and treatment, including devices linked to snoring/OSA care.
  • In April 2025, Health Canada and Canadian government agencies actively promote awareness of sleep disorders and support regulations that improve access to diagnostic and therapeutic solutions, fostering a supportive environment for device adoption.

Segmental Insights

Device Type Insights

Which Device Type Segment Dominated the Anti-Snoring Devices Market?

The oral appliances segment dominates the market because these devices offer a simple, non-invasive, and comfortable solution for improving airflow during sleep. They are widely preferred due to their ease of use, portability, and effectiveness in reducing mild to moderate snoring. Increased recommendations from sleep specialists, growing adoption of custom-fit designs, and rising consumer preference for home-based, low-maintenance treatments further strengthen this segment’s leadership.

EPAP Therapy Devices

The EPAP therapy devices segment is estimated to be the fastest growing due to their non-invasive design, ease of use, and proven effectiveness in improving nighttime airflow. These devices require no power source, making them convenient for home and travel use. Growing clinical validation and rising preference for simple, low-maintenance snoring solutions further accelerate their adoption.

Gender Insights

Why Did the Male Patients Segment Dominate the Anti-Snoring Devices Market?

The male patients segment dominated the market in 2025 because snoring and sleep apnea are more prevalent among men due to anatomical factors, lifestyle habits, and higher rates of obesity. Greater diagnosis of sleep-related disorders and stronger adoption of home-based treatment solutions among men further contribute to the segment’s leading market share.

Female Patients

The female patients segment is anticipated to be the fastest-growing in the anti-snoring devices market due to rising awareness of sleep health among women, increasing diagnosis of sleep-related disorders, and growing focus on wellness and preventive care. Changing lifestyle patterns, stress-related sleep issues, and higher adoption of non-invasive homecare solutions further accelerate segment growth.

Age Group Insights

Why Did the Segment Above 60 Years Dominate the Anti-Snoring Devices Market in 2025?

The above 60 years segment dominates the market because snoring and sleep apnea become more common with age due to muscle relaxation in the airway and age-related respiratory changes. Higher diagnosis rates, greater reliance on medical sleep aids, and increased adoption of non-invasive homecare devices further strengthen this segment’s leading position.

Percentage Aged 65+ (of Total Population)

Year Percent aged 65+ (of total population)
2022 8.90%
2023 9.80%
2024 10.00%
2025 11.30%

Between 40-60 Years

The between 40-60 years segment is estimated to be the fastest-growing in the anti-snoring devices market due to rising lifestyle-related sleep disorders, higher stress levels, and increasing obesity rates in this age group. Growing awareness of sleep health, early diagnosis of snoring and mild sleep apnea, and strong preference for convenient, non-invasive homecare devices are further driving rapid adoption.

Distribution Channel Insights

Which Distribution Channel Segment Led the Anti-Snoring Devices Market?

The hospital pharmacies segment dominated the market in 2025 because hospitals serve as primary points for diagnosis and prescription of snoring and sleep apnea treatments. Strong collaborations with healthcare providers, availability of clinically validated devices, and trust in professional guidance drive higher adoption. Additionally, hospital pharmacies facilitate access to advanced and custom-fit anti-snoring solutions, reinforcing their market leadership.

Online Pharmacies

The online pharmacies segment is anticipated to be the fastest-growing in the market due to the convenience of home delivery, wider product variety, and easy access to both standard and advanced devices. Rising e-commerce adoption growing consumer preference for contactless purchases, and availability of customer reviews and guidance further accelerate the segment’s rapid growth.

End User Insights

Why is Home Care Settings the dominant segment in the Anti-Snoring Devices Market?

The home care settings segment dominates the market due to increasing consumer preference for convenient, non-invasive, and self-administered solutions. Growing awareness of sleep health, rising lifestyle-related sleep disorders, and the availability of easy-to-use devices, such as oral appliances and smart wearables, drive adoption. Additionally, the comfort, privacy, and flexibility offered by home-based treatments further strengthen this segment’s leadership.

Hospitals & Clinics

The hospitals & clinics segment is estimated to be the fastest-growing due to increasing diagnoses of sleep disorders rising referrals from healthcare professionals, and the adoption of clinically validated anti-snoring devices. Advanced treatment options and growing patient awareness further drive rapid uptake in medical settings.

Regional Distribution

Anti-Snoring Devices Market Share, By Region, 2025 (%)

  • North America registered dominance in the anti-snoring devices market in 2025.
  • The U.S. led the market by capturing the largest revenue share of the market in 2025.
  • Asia Pacific is expected to be the fastest-growing region in the studied years.
  • China is anticipated to grow at a rapid CAGR during the forecast period.
  • Europe is expected to grow at a significant CAGR in the market during the forecast period.
  • UK is anticipated to grow at a rapid CAGR during the forecast period.

Which Factors Made the North America Region the Dominant Region in the Market?

North America dominates the market due to high awareness of sleep disorders, widespread adoption of home-based sleep solutions, and the strong presence of leading device manufacturers. Advanced healthcare infrastructure, higher diagnosis rates of sleep apnea, and growing use of smart, technology-enabled sleep aids further strengthen the region’s market leadership.

The U.S. dominates the North America anti-snoring devices market due to strong consumer awareness, high prevalence of sleep-related disorders, and rapid adoption of innovative, non-invasive sleep solutions. Robust healthcare support, availability of advanced diagnostic facilities, and the presence of key device manufacturers further boost the country’s leadership. Additionally, strong demand for smart, connected sleep devices enhances its market dominance.

Which Factors Influence the Fastest Growth of the Asia Pacific Market?

Asia-Pacific is the fastest-growing region in the anti-snoring devices market due to rising awareness of sleep health, increasing urban stress levels, and growing lifestyle-related sleep disorders. Expanding healthcare access, rising disposable incomes, and greater acceptance of affordable, non-invasive sleep solutions are accelerating adoption. Additionally, technological advancements and the availability of mobile-linked smart devices support rapid regional growth.

China dominates the Asia-Pacific market due to its large population affected by lifestyle-driven sleep disorders, increasing awareness of sleep health, and strong adoption of affordable homecare solutions. The country benefits from rapid technological innovation, expanding local manufacturing capabilities, and growing availability of smart, app-connected devices. Rising healthcare spending and wider access to sleep diagnostics further reinforce China’s market leadership.

How Big is the Success of Europe in the Market?

Europe is growing at a notable rate in the anti-snoring devices market due to rising awareness of sleep-related disorders, strong adoption of non-invasive treatment options, and increasing emphasis on home-based sleep solutions. Supportive healthcare policies, technological innovation, and expanding access to advanced diagnostic services further accelerate the region’s growth.

The UK dominates the European market due to high awareness of sleep disorders, strong preference for clinically validated, non-invasive solutions, and widespread availability of advanced diagnostic services. The country benefits from robust healthcare support, rapid adoption of smart sleep technologies, and a strong presence of leading manufacturers and distributors, which collectively reinforce its regional leadership.

Value Chain Analysis: Anti-Snoring Devices Market

Research & Development (R&D)

  • Conduct market assessment, design and prototype devices, develop materials and engineering solutions, integrate sensors or digital features, and validate concepts for efficacy and comfort.
  • Organizations: ResMed Inc., Philips Respironics, SomnoMed Ltd., Apnea Sciences/ZQuiet, academic labs, and professional societies like the American Academy of Sleep Medicine.

Clinical Trials & Regulatory Approval

  • Perform pre-clinical safety testing, conduct human clinical studies to assess effectiveness, prepare regulatory dossiers, and obtain approvals or clearances from relevant authorities.
  • Organizations: FDA (U.S.), European CE marking bodies, clinical research centers, sleep clinics, and professional associations such as AASM.

Patient Support & Services

  • Provide diagnosis through sleep assessments, prescribe and fit devices, educate patients on usage, monitor adherence, offer follow-up support, and create awareness about treatment benefits.
  • Organizations: Sleep clinics, pulmonologists, dental sleep specialists, American Sleep Apnea Association (ASAA), National Sleep Foundation (NSF), telehealth platforms, and insurance providers.

Top Vendors in the Anti-Snoring Devices Market & Their Offerings

Anti-Snoring Devices Market Key Players

Vendor Main anti-snoring offerings Headquarters
ResMed CPAP devices & masks (sleep-disordered-breathing portfolio); also supports oral-appliance therapy as part of treatment options. San Diego, California, USA.
Philips Respironics (Royal Philips) NightBalance positional therapy device (a wearable that reduces positional OSA/snoring); broad sleep/respiratory portfolio. Amsterdam / global HQ for Philips is the Netherlands (Philips Respironics operations in multiple countries).
SomnoMed Prescription custom mandibular advancement devices (oral appliances / MRDs) for snoring and mild–moderate OSA. Sydney, New South Wales, Australia.
ProSomnus Sleep Technologies Precision, custom-fit mandibular advancement devices (digital/custom MADs) are marketed as a non-CPAP therapy. Pleasanton / San Francisco Bay Area (headquarters & manufacturing), California, USA.
Fisher & Paykel Healthcare CPAP masks, nasal interfaces, and related respiratory devices are used in the treatment of snoring/OSA.  East Tāmaki (Auckland), New Zealand.
Vivos Therapeutics Vivos CARE oral medical devices (DNA/mRNA appliances) that expand airway/arch — used to reduce snoring and treat OSA. Highlands Ranch / Littleton, Colorado, USA.
ZQuiet (Sleeping Well LLC) OTC mandibular advancement mouthpieces (ready-to-use/consumer MADs) to reduce snoring. Lewiston / United States (company based in the U.S.).
Theravent (TheraVent / Provent technology) EPAP-based disposable nasal devices / OTC and prescription EPAP therapy (creates expiratory positive airway pressure to reduce snoring/OSA).  San Jose, California, USA.
Smart Nora Contact-free “smart pillow” system that detects snoring and gently repositions the head/pillow to stop snoring episodes Toronto, Ontario, Canada.
Panthera Dental / Panthera Sleep CAD/CAM custom intraoral sleep appliances (D-SAD and other MADs) for snoring and mild–moderate OSA. Québec, Québec, Canada.

SWOT Analysis: Anti-Snoring Devices Market

Strengths

  • Growing awareness of sleep disorders and non-invasive treatment options.
  • Wide product variety, including smart, app-connected devices.
  • Strong demand for home-based sleep solutions.
  • Increasing technological advancements are enhancing accuracy and comfort.

Weaknesses

  • Limited effectiveness for severe sleep apnea cases.
  • High cost of advanced smart devices.
  • Inconsistent user compliance and comfort issues.
  • Lack of standardized clinical validation across all products.

Opportunities

  • Expansion in developing markets driven by rising sleep-health awareness.
  • Integration of AI, IoT, and real-time monitoring features.
  • Growing e-commerce adoption is increasing product accessibility.
  • Rising partnerships between device makers and sleep clinics.

Threats

  • Competition from alternative treatments like CPAP therapy.
  • Regulatory challenges and product approval delays.
  • Presence of low-quality, unregulated products affecting consumer trust.
  • Increasing prevalence of counterfeit devices in online markets.

Recent Developments in the Anti-Snoring Devices Market

  • In October 2025, Hushd Pro received FDA clearance for its Z-Link oral appliance, a 3D-printed mandibular advancement device. This innovative solution provides a tailored fit for individual users, enhancing comfort while effectively mitigating snoring and mild sleep apnea. Its launch underscores the increasing adoption of precision-engineered oral devices in the anti-snoring market.
  • In August 2025, SnailSleep introduced its AI-powered OSA Screening & Monitoring tool, a smartphone-based solution designed to detect snoring patterns and assess the risk of obstructive sleep apnea without the need for additional hardware. The device leverages advanced AI algorithms, enabling users to monitor sleep health conveniently from home, reflecting a growing trend toward tech-enabled, non-invasive sleep solutions.
  • In August 2025, SleepZee launched its custom-fit anti-snoring mouthpiece, aimed at improving airway alignment and reducing snoring. The device emphasizes comfort and personalization, catering to users seeking effective, home-based oral appliances for mild to moderate snoring issues.

Segments Covered in the Report

By Device Type

  • Oral Appliances
  • Tongue-Retaining/Stabilizing Devices
  • Nasal Devices
  • Position Control Devices
  • Chin Straps
  • EPAP Therapy Devices

By Gender

  • Male Patients
  • Female Patients

By Age Group

  • Below 40 Years
  • Between 40-60 Years
  • Above 60 Years

By Distribution Channel

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

By End User

  • Home Care Settings
  • Hospitals & Clinics

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe 
      • Austria
      • Russia & Belarus 
      • Türkiye
      • Albania 
      • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

The anti-snoring devices market holds a valuation of USD 2.06 billion as of 2026, and will expand to USD 3.89 billion by 2035, achieving a CAGR of 7.34% between 2026 and 2035.

North America is currently leading the anti-snoring devices market due to high awareness of sleep disorders, widespread adoption of advanced healthcare technologies, strong presence of key market players, and increasing consumer preference for homecare solutions.

The anti-snoring devices market includes 6 segments by device type, by gender, by age group, by distribution channel, by end-user, and by region.

Some key players include Apnea Sciences Corp., SomnoMed Ltd., Airway Management, Inc., ResMed Inc., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips NV, Sleep Well Enjoy Life, Ltd., Tomed Dr. Toussaint GmbH, and MEDiTAS Ltd among others.

Key trends include smart and connected devices, home-based and wearable solutions, and expansion in clinical and wellness settings, among others.

British Snoring & Sleep Apnoea Association, National Institutes of Health, Ministry of Health and Family Welfare, Government of India, American Academy of Sleep Medicine AASM Medical Society, FDA, WHO, Sleep-Onset Association Disorder, PIB, CDC.

Tags

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports